Analysis of a startup: Neurode
Wed, 28 Apr
|Online meeting details will be emailed
A panel of experts recommend the optimal path to commercialisation for a real-life startup focused on ADHD.
Time & Location
28 Apr 2021, 12:00 pm – 1:00 pm AEST
Online meeting details will be emailed
About the event
In this webinar, a panel of experts discuss the key success factors for MedTech start-ups, analysing the case of Neurode. The Neurode Wave is wearable headset being developed by Nathalie Gouailhardou and Damian Sofrevski to improve cognitive performance for people with neurological conditions.
The start-ups inital target market is Attention-Deficit/Hyperactivity-Disorder (ADHD) where 30% of people with the condition are drug-resistant, leaving them with no accessible or effective treatment options.
The Neurode Wave can be worn in short daily sessions at home to improve symptoms like working memory, attention and impulse control. Currently, Neurode have an MVP which has been validated by collecting data from 12 healthy people.
Nathalie is both a neuroscientist, and a person with ADHD, giving her unique insight into the problems faced and how to best address them. Damian is an electrical engineer and physicist.